Enveric Biosciences, Inc. released an Investor Presentation for the second quarter of 2026. The presentation is intended for use in discussions with investors, analysts, lenders, and potential business partners. Enveric Biosciences, Inc. is a biotechnology company focused on developing drug delivery technologies and itself as a platform for a drug discovery platform.
